메뉴 건너뛰기




Volumn 59, Issue 3, 2012, Pages 333-337

Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin

Author keywords

HCV; HIV; IL28B; Interferon; Ribavirin; Sustained virologic response

Indexed keywords


EID: 84873707575     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2012_2117     Document Type: Article
Times cited : (10)

References (28)
  • 1
    • 79953107054 scopus 로고    scopus 로고
    • Evaluation of prognostic factors for Peg Interferon alfa-2b plus ribavirin treatment on HCV infected patients in Pakistan
    • Aziz H, Gil ML, Waheed Y, Adeeb U, Raza A, Bilal I, Athar MA (2011) Evaluation of prognostic factors for Peg Interferon alfa-2b plus ribavirin treatment on HCV infected patients in Pakistan. Infect Genet Evol 11: 640-645.
    • (2011) Infect Genet Evol , vol.11 , pp. 640-645
    • Aziz, H.1    Gil, M.L.2    Waheed, Y.3    Adeeb, U.4    Raza, A.5    Bilal, I.6    Athar, M.A.7
  • 2
    • 0028806153 scopus 로고
    • Chronic hepatitis. An update on terminology and reporting
    • Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19: 1409-1417.
    • (1995) Am J Surg Pathol , vol.19 , pp. 1409-1417
    • Batts, K.P.1    Ludwig, J.2
  • 3
    • 33646250428 scopus 로고    scopus 로고
    • The natural history of hepatitis C virus (HCV) infection
    • Chen SL, Morgan TR (2006) The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 3: 47-52.
    • (2006) Int J Med Sci , vol.3 , pp. 47-52
    • Chen, S.L.1    Morgan, T.R.2
  • 5
    • 80054897004 scopus 로고    scopus 로고
    • The role of insulin resistance in HIV/hepatitis C virus-coinfected patients
    • Eslam M, López-Cortés LF, Romero-Gomez M (2011) The role of insulin resistance in HIV/hepatitis C virus-coinfected patients. Curr Opin HIV AIDS 6: 553-558.
    • (2011) Curr Opin HIV AIDS , vol.6 , pp. 553-558
    • Eslam, M.1    López-Cortés, L.F.2    Romero-Gomez, M.3
  • 6
    • 4444278724 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis C infection with peginterferons plus ribavirin
    • Fried M, Hadziyannis S (2004) Treatment of chronic hepatitis C infection with peginterferons plus ribavirin. Semin Liver Dis 24: 47-54.
    • (2004) Semin Liver Dis , vol.24 , pp. 47-54
    • Fried, M.1    Hadziyannis, S.2
  • 11
    • 62149105964 scopus 로고    scopus 로고
    • A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients
    • Idrees M, Riazuddin S (2009) A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients. BMC Gastroenterol 20: 5.
    • (2009) BMC Gastroenterol , vol.20 , pp. 5
    • Idrees, M.1    Riazuddin, S.2
  • 13
    • 34047262154 scopus 로고    scopus 로고
    • Viral hepatitis in HIV infection
    • Koziel M, Peters M (2007) Viral hepatitis in HIV infection. N Engl J Med 356: 1445-1454.
    • (2007) N Engl J Med , vol.356 , pp. 1445-1454
    • Koziel, M.1    Peters, M.2
  • 14
    • 0035811625 scopus 로고    scopus 로고
    • Hepatitis C virus infection
    • Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345: 41-52.
    • (2001) N Engl J Med , vol.345 , pp. 41-52
    • Lauer, G.M.1    Walker, B.D.2
  • 17
    • 1642465363 scopus 로고    scopus 로고
    • Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy
    • Myers RP, Benhamou Y, Bochet M, Thibault V, Mehri D, Poynard T (2004) Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy. AIDS 18: 75-79.
    • (2004) AIDS , vol.18 , pp. 75-79
    • Myers, R.P.1    Benhamou, Y.2    Bochet, M.3    Thibault, V.4    Mehri, D.5    Poynard, T.6
  • 18
    • 77953393036 scopus 로고    scopus 로고
    • Predicting the probable outcome of treatment in HCV patients
    • Navaneethan U, Kemmer N, Neff GW (2009) Predicting the probable outcome of treatment in HCV patients. Therap Adv Gastroenterol 2: 287-302.
    • (2009) Therap Adv Gastroenterol , vol.2 , pp. 287-302
    • Navaneethan, U.1    Kemmer, N.2    Neff, G.W.3
  • 20
    • 80555127355 scopus 로고    scopus 로고
    • Drugs in development for chronic hepatitis C: a promising future
    • Pockros PJ (2011) Drugs in development for chronic hepatitis C: a promising future. Expert Opin Biol Ther 11: 1611-1622.
    • (2011) Expert Opin Biol Ther , vol.11 , pp. 1611-1622
    • Pockros, P.J.1
  • 21
    • 85027955533 scopus 로고    scopus 로고
    • IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin
    • Rallón NI, Soriano V, Naggie S, Restrepo C, Goldstein D, Vispo E Thompson A, McHutchison J, Soriano V (2011) IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin. AIDS 15: 1025-1033.
    • (2011) AIDS , vol.15 , pp. 1025-1033
    • Rallón, N.I.1    Soriano, V.2    Naggie, S.3    Restrepo, C.4    Goldstein, D.5    Vispo, E.6    Thompson, A.7    McHutchison, J.8    Soriano, V.9
  • 23
    • 70349242026 scopus 로고    scopus 로고
    • Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients
    • Reddy KR, Messinger D, Popescu M, Hadziyannis SJ (2009) Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients. J Viral. Hepatol 16: 724-731.
    • (2009) J Viral. Hepatol , vol.16 , pp. 724-731
    • Reddy, K.R.1    Messinger, D.2    Popescu, M.3    Hadziyannis, S.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.